Catalys Pacific, LLC Hille Vax, Inc. Transaction History
Catalys Pacific, LLC
- $125 Billion
- Q3 2024
A detailed history of Catalys Pacific, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Catalys Pacific, LLC holds 236,379 shares of HLVX stock, worth $439,664. This represents 0.33% of its overall portfolio holdings.
Number of Shares
236,379
Previous 1,208,974
80.45%
Holding current value
$439,664
Previous $17.5 Billion
97.62%
% of portfolio
0.33%
Previous 13.19%
Shares
3 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.8MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.7 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.15 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.89 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.64 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.5 Million0.06% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $62.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.